Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2026-05-07 @ 8:58 AM
Study NCT ID:
NCT01553656
Status:
COMPLETED
Last Update Posted:
2015-08-20
First Post:
2012-03-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer
Sponsor:
Exelixis
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
XL184-014
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None